Table 2.
Key findings from previous HPV prevalence studies in transpeople published in peer-reviewed literature in comparison to findings of the present study.
| n | HPV positivity in FtM | HPV positivity in MtF | HPV positivity in genderqueer/non binary/other | Site | HPV Assay used | Research Objective | |
|---|---|---|---|---|---|---|---|
| Reisner et al.5 | 131 | 16·0% (21/131) | Cervicovaginal | Digene Hybrid Capture II (Qiagen) | Self- versus provider-collected swabs | ||
| Loverro et al.6 | 35 | 21·4% (3/14) | 52·4% (11/21) | Anal (Oral, vaginal, cervicovaginal, penile not presented) | Linear Array Genotyping Assay (Roche) | HPV prevalence | |
| Van der Sluis et al.7 | 52 | 11·5% (6/52) | Neovaginal | HPV-Risk assay (Self-Screen BV) | HPV prevalence | ||
| Cranston et al.8 | 13 | 69·2% (9/13) | Anal | Papillocheck (Greiner) | HPV prevalence | ||
| Singh et al.9 | 44 | 88·6% (39/44) | Anal (oral, serum not presented) | Linear Array Genotyping Assay (Roche) | HPV prevalence | ||
| Brown et al.17 | 68 | 95·6% (65/68) | Anal, penile | Linear Array Genotyping Assay (Roche) | HPV and HIV prevalence in a cohort in which a majority received money or favours for sex | ||
| Jalil et al. 18 | 272 | 77·9% (212/272) | Anal | Papillocheck (Greiner) | HPV prevalence in a cohort with a large sex-worker rate | ||
| Pils et al. | 195 | 24·2% (22/91) | 11·8% (10/85) | 26·3% (5/19) | Urine | Anyplex II HPV 28 Detection (Seegene) | HPV prevalence |
Abbreviations used: n, number; FtM, female to male; MtF, male to female; HPV, human papillomavirus; HIV, human immunodeficiency virus.
Digene Hybrid Capture II (Qiagen, Gaithersburg, MD, USA): HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68.
Linear Array HPV Genotyping Test (Roche Molecular Systems, Branchburg, NJ, USA): HPV genotypes 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 64, 66, 67, 68, 69, 70, 71, 72, 73, 81, 82, 83, 84, 89, IS39.
HPV-Risk assay (Self-Screen BV, Amsterdam, Netherlands): HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, 68.
Papillocheck (Greiner Bio-One, Frickenhausen, Germany): HPV genotypes 6, 11, 40, 42, 43, 44, 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 70, 73, 82.
Anyplex II HPV 28 Detection (Seegene, Seoul, South Korea): HPV genotypes 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 69, 70, 73, 82.